https://orcid.org/0000-0002-6682-5529
References
- Hon KL, Pong NH, Poon TC, et al. Quality of life and psychosocial issues are important outcome measures in eczema treatment. J DermatologTreat. 2015;26(1):83–89.
- Leung AK, Hon KL, Robson WL. Atopic dermatitis. Adv Pediatr. 2007. 54(1):241–73.
- Leung TN, Hon KL. Eczema therapeutics in children: what do the clinical trials say? Hong Kong Med J. 2015;21(3):10.
- Slattery MJ, Essex MJ, Paletz EM, et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol. 2011;128(3):668–671.
- Magin PJ, Pond CD, Smith WT, et al. Correlation and agreement of self-assessed and objective skin disease severity in a cross-sectional study of patients with acne, psoriasis, and atopic eczema. Int J Dermatol. 2011;50(12):1486–1490. Dec
- Hon KL, Bao YM, Chan KC, et al. Determinants for asthma control, quality of life and use of complementary and alternative medicine in asthmatic pediatric patients in four cities. World J Pediatr. 2018;14(5):482–491.
- Howells LM, Chalmers JR, Gran S, et al. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP). Br J Dermatol. 2020;183(3):524–536.
- Pariser DM, Simpson EL, Gadkari A, et al. Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT). Curr Med Res Opin. 2020;36(3):367–376.
- Williams HC, Burney G, Pembroke AC, et al. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol. 1994;131(3):406–416.
- European Task Force on Atopic Dermatitis. Severity Scoring of Atopic Dermatitis: The SCORAD Index. Dermatology. 1993;186(1):23–31.
- Emerson RM, Charman CR, Williams HC. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol. 2000;142(2):288–97.
- Hon KL, Ma KC, Wong E, et al. Validation of a Self-Administered Questionnaire in Chinese in the Assessment of Eczema Severity. Pediatr Dermatol. 2003;20(6):465–469.
- Gaunt DM, Metcalfe C, Ridd M. The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference. Allergy. 2016;71(11):1620–1625.
- Hon KL, Kung JSC, Tsang KYC, et al. Do we need another symptom score for childhood eczema? J Dermatol Treat. 2018;29(5):510–514.
- Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol. 2004;150(2):284–290.
- Chuh AA. Validation of a Cantonese version of the Children’s Dermatology Life Quality Index. Pediatr Dermatol. 2003;20(6):479–81.
- Xi-Yao G, Rui X, Yue-Jia L. XX. Psychometric properties of the Chinese versions of DASS-21 in Chinese college students. Chinese J Clin Psychol. 2010;18(4):443–446. Chinese.
- Elliman MG, Sloman P, South M, et al. Action plans into action – an electronic action plan generation tool at a paediatric centre. Int J Med Inform. 2020;141:104219.
- Shelley AJ, McDonald KA, McEvoy A, et al. Usability, satisfaction, and usefulness of an illustrated eczema action plan. J Cutan Med Surg. 2018;22(6):577–582.
- Powell K, Le Roux E, Banks JP, et al. Developing a written action plan for children with eczema: a qualitative study. Br J Gen Pract. 2018;68(667):e81–e89.
- Brown J, Weitz NW, Liang A, et al. Does an eczema action plan improve atopic dermatitis? A single-site randomized controlled trial. Clin Pediatr (Phila). 2018;57(14):1624–1629.
- Rork JF, Sheehan WJ, Gaffin JM, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–392.